Molecular targets and subtypes in melanoma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Oncology is entering a new era in which patients are being categorized not only by the tissue of origin of their cancer, but also by the molecular characteristics of their tumor. Historically, melanomas have been classified as cutaneous (including superficial spreading, nodular, lentigo maligna, and acral lentiginous subtypes), mucosal, or uveal. Recent molecular analyses have demonstrated that the majority of melanomas harbor one or more genetic alterations in components of key signaling networks. This information is now being integrated with the traditional clinicopathological criteria to develop a more refined system that has both diagnostic and therapeutic implications.

Original languageEnglish (US)
Title of host publicationTargeted Therapeutics in Melanoma
PublisherSpringer New York
Pages3-15
Number of pages13
ISBN (Electronic)9781617794070
ISBN (Print)9781617794063
DOIs
StatePublished - Jan 1 2012

Keywords

  • AKT
  • Acral lentiginous melanoma
  • Amplification
  • BRAF
  • Comparative genome hybridization
  • GNA11
  • GNAQ
  • Imatinib
  • KIT
  • MAPK
  • MEK
  • Mucosal melanoma
  • Mutation
  • NRAS
  • Nevi
  • Nodular melanoma
  • Oncogene addiction
  • PI3K
  • PLX4032
  • PTEN
  • Superficial spreading melanoma
  • Targeted therapy
  • Uveal melanoma

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Molecular targets and subtypes in melanoma'. Together they form a unique fingerprint.

Cite this